In its response, the ITC stated that “Amarin’s complaint does not allege an unfair method of competition or an unfair act cognizable under 19 U.S.C. § 1337(a)(1)(A), as required by the statute and the Commission’s rules.”
The company showcased new innovative delivery forms for its collagen peptide ingredients and discussed the research that is helping it make inroads in two key market segments: nutricosmetics and muscle health.
Industry, take note! Dietary supplements of all stripes (herbal, botanical, vitamins, minerals, marine-based, and others) are the subjects of numerous NIH research studies and clinical trials this year.